These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 17680526)
1. [The relationship of mTOR signaling pathway and histone acetylation in human gastric cancer cell lines]. Sun DF; Fang JY; Zhang YJ; Tian XQ; Zhu HY; Li EL; Gu WQ; Shen GF Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):387-91. PubMed ID: 17680526 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation. Sun DF; Zhang YJ; Tian XQ; Chen YX; Fang JY Cell Biol Int; 2014 Jan; 38(1):50-63. PubMed ID: 24030871 [TBL] [Abstract][Full Text] [Related]
3. Mammalian target of rapamycin pathway inhibition enhances the effects of 5-aza-dC on suppressing cell proliferation in human gastric cancer cell lines. Sun D; Toan X; Zhang Y; Chen Y; Lu R; Wang X; Fang J Sci China C Life Sci; 2008 Jul; 51(7):640-7. PubMed ID: 18622747 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924 [TBL] [Abstract][Full Text] [Related]
5. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. Bishop JD; Nien WL; Dauphinee SM; Too CK J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564 [TBL] [Abstract][Full Text] [Related]
6. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. Chen YX; Fang JY; Lu J; Qiu DK Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516 [TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling. Zhang P; Guo Z; Wu Y; Hu R; Du J; He X; Jiao X; Zhu X PLoS One; 2015; 10(8):e0136193. PubMed ID: 26287365 [TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459 [TBL] [Abstract][Full Text] [Related]
9. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679 [TBL] [Abstract][Full Text] [Related]
11. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051 [TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. García-Maceira P; Mateo J Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810 [TBL] [Abstract][Full Text] [Related]
13. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy. Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503 [TBL] [Abstract][Full Text] [Related]
14. [Synergistic effect of rapamycin (RPM) and PD98059 on cell cycle and mTOR signal transduction in human colorectal cancer cells]. Zhang YJ; Fang JY; Sun DF; Zhao SL; Shen GF; Zheng Q; Zhu HY Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):889-93. PubMed ID: 18478925 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209 [TBL] [Abstract][Full Text] [Related]
16. Activation of phosphatidylinositol-3'-kinase/AKT signaling is essential in hepatoblastoma survival. Hartmann W; Küchler J; Koch A; Friedrichs N; Waha A; Endl E; Czerwitzki J; Metzger D; Steiner S; Wurst P; Leuschner I; von Schweinitz D; Buettner R; Pietsch T Clin Cancer Res; 2009 Jul; 15(14):4538-45. PubMed ID: 19584164 [TBL] [Abstract][Full Text] [Related]
17. Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling. Quan P; Moinfar F; Kufferath I; Absenger M; Kueznik T; Denk H; Zatloukal K; Haybaeck J Anticancer Res; 2014 Jun; 34(6):2883-97. PubMed ID: 24922651 [TBL] [Abstract][Full Text] [Related]
18. Determinants of rapamycin sensitivity in breast cancer cells. Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980 [TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Liu FY; Zhao ZJ; Li P; Ding X; Zong ZH; Sun CF Br J Oral Maxillofac Surg; 2010 Jun; 48(4):291-6. PubMed ID: 19615795 [TBL] [Abstract][Full Text] [Related]
20. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors. Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]